Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334302983> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- W2334302983 endingPage "A97" @default.
- W2334302983 startingPage "A96" @default.
- W2334302983 abstract "<h3>Background</h3> Laquinimod is an immunomodulatory compound that reduces relapse rate, brain atrophy and disability progression in multiple sclerosis. It has well-documented effects on inflammation, is widely distributed in the CNS and has been shown to ameliorate axonal damage <i>in vitro</i>and <i>in vivo</i>through an unknown mechanism. We have shown recently that caspase-6 is an important mediator in axonal degeneration, since sympathetic neurons derived from caspase-6 -/- mice do not degenerate when cultured in the absence of neuronal growth factor (NGF). We therefore investigated whether the beneficial effect of Laquinimod on axonal damage is mediated by caspase-6. <h3>Aim</h3> To investigate neuron-specific beneficial effects of Laquinimod. <h3>Methods</h3> Cell-free and cell-based enzymatic activity assays were used to determine whether Laquinimod directly inhibits caspase-6. To investigate an effect on intraneuronal caspase-6 activity, primary cortical neurons were treated with camptothecin in the presence or absence of Laquinimod, and cleavage of the caspase-6 specific substrate lamin A was quantified by ELISA. Axonal degeneration of primary sympathetic neurons from the superior cerebral ganglion was induced by NGF withdrawal in the presence or absence of Laquinimod. <h3>Results</h3> Laquinimod did not directly inhibit caspase-6 activity in cell-free or transfection-based cellular systems. However, the presence of Laquinimod in camptothecin-stressed primary cortical neuron cultures led to a significant decrease in caspase-6 activation. In cultures of primary superior cerebral ganglion neurons, Laquinimod partially protected axons from degeneration after NGF withdrawal, a process that is specifically dependent on caspase-6 activity, in agreement with the reduction of caspase-6 activity observed in stressed cortical neurons. <h3>Conclusions</h3> The beneficial effects of Laquinimod described so far involve neuroprotection through the downregulation of glial activation, whereas our findings represent a novel, purely neuronal mechanism of action for this drug. We propose that by preventing neuronal caspase-6 activation and axonal degeneration, Laquinimod might also provide benefits in other neurodegenerative disorders such as Huntington’s disease that are associated with excessive activation of caspase-6." @default.
- W2334302983 created "2016-06-24" @default.
- W2334302983 creator A5010528585 @default.
- W2334302983 creator A5010732739 @default.
- W2334302983 creator A5047267227 @default.
- W2334302983 creator A5050214513 @default.
- W2334302983 creator A5083002289 @default.
- W2334302983 date "2014-09-01" @default.
- W2334302983 modified "2023-09-27" @default.
- W2334302983 title "M08 Laquinimod Reduces Neuronal Caspase-6 Activation And Axonal Degeneration In Vitro" @default.
- W2334302983 doi "https://doi.org/10.1136/jnnp-2014-309032.280" @default.
- W2334302983 hasPublicationYear "2014" @default.
- W2334302983 type Work @default.
- W2334302983 sameAs 2334302983 @default.
- W2334302983 citedByCount "0" @default.
- W2334302983 crossrefType "journal-article" @default.
- W2334302983 hasAuthorship W2334302983A5010528585 @default.
- W2334302983 hasAuthorship W2334302983A5010732739 @default.
- W2334302983 hasAuthorship W2334302983A5047267227 @default.
- W2334302983 hasAuthorship W2334302983A5050214513 @default.
- W2334302983 hasAuthorship W2334302983A5083002289 @default.
- W2334302983 hasConcept C169760540 @default.
- W2334302983 hasConcept C25498285 @default.
- W2334302983 hasConcept C86803240 @default.
- W2334302983 hasConcept C98274493 @default.
- W2334302983 hasConceptScore W2334302983C169760540 @default.
- W2334302983 hasConceptScore W2334302983C25498285 @default.
- W2334302983 hasConceptScore W2334302983C86803240 @default.
- W2334302983 hasConceptScore W2334302983C98274493 @default.
- W2334302983 hasIssue "Suppl 1" @default.
- W2334302983 hasLocation W23343029831 @default.
- W2334302983 hasOpenAccess W2334302983 @default.
- W2334302983 hasPrimaryLocation W23343029831 @default.
- W2334302983 hasRelatedWork W2034754355 @default.
- W2334302983 hasRelatedWork W2050697792 @default.
- W2334302983 hasRelatedWork W2067467642 @default.
- W2334302983 hasRelatedWork W2077302930 @default.
- W2334302983 hasRelatedWork W2084272464 @default.
- W2334302983 hasRelatedWork W2747715884 @default.
- W2334302983 hasRelatedWork W2889659746 @default.
- W2334302983 hasRelatedWork W2965035470 @default.
- W2334302983 hasRelatedWork W3143637439 @default.
- W2334302983 hasRelatedWork W70727126 @default.
- W2334302983 hasVolume "85" @default.
- W2334302983 isParatext "false" @default.
- W2334302983 isRetracted "false" @default.
- W2334302983 magId "2334302983" @default.
- W2334302983 workType "article" @default.